Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology     Life Sciences Research    

Global Microfluidics Market Research Report

The Global Microfluidics Market is mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, cardiovascular diseases, brain disorders and sleep disorders. This market was valued at $1.59 billion in 2013 and is poised to reach $3.57 billion by 2018 at a CAGR of 17.6%.

 

The report “Global Microfluidics Market forecast, 2012-2018” analyzes the market segmentation by type such as polymer-based materials, glass-based materials, silicon-based materials, and other material based microfluidics. All these segments experienced a positive growth till 2018 with an increased awareness for procedures and sophisticated diagnostic techniques.

 

North America commands the largest share of the microfluidics materials market, followed by Europe and Asia. The global Polymer-based materials segment accounts for the largest share of around 71% of the global microfluidics materials market and was valued at $1.08 billion, and is expected to reach $2.7 billion by 2018, at a CAGR of 20.3%, for the given period. The global glass-based materials market accounts for the share of around 21% of the global microfluidics materials market. It is expected to reach a CAGR of 9.3%, for the given period. The global silicon-based materials market accounts for the share of around 9% of the global microfluidics materials market. It is expected to reach a CAGR of 9.3%, for the given period.

 

North America commands the largest share of the microfluidics materials market. It was estimated to be $669 million in 2013 and is expected to reach $1.5 billion by 2018 at a CAGR of 17.4%. This large share is due to the presence of a large number of major manufacturers such as Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences (Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.). Asia is expected to grow at the highest CAGR of 20.9%, for the given period.

Major factors driving the growth of the market are increasing number of investments, lower material costs, and large number of local startup companies in countries such as China and India.

The report also provides an extensive competitive landscaping of companies operating in biomaterials market. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)

Products and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

show more
PRODUCT TITLE PUBLISHED
North American Microfluidics Market North American Microfluidics Market
The North American Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $669 million in 2013 and is poised to grow at a CAGR of  17.4% to reach $1496 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
European Microfluidics European Microfluidics
The European Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which  was valued at $420 million in 2013 and is poised to grow at a CAGR of  15.2% to reach $852 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
Asian Microfluidics Market Asian Microfluidics Market
The Asian Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $369 million in 2013 and is poised to grow at a CAGR of  20.9% to reach $952 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany)
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539